You have not yet registered? Get your account for free.
Forgot Password? We will send you a reset link
7 November 2019
InflaRx Reports Third Quarter 2019 Financial & Operating Results
6 November 2019
InflaRx Reports Positive Results from the Open Label Extension Part of the SHINE Study for IFX-1 in Hidradenitis Suppurativa (news with additional features)
8 March 2018
InflaRx announces first patient enrolled in Phase IIb trial with lead candidate IFX-1 in Hidradenitis Suppurativa
6 February 2018
InflaRx announces appointment of Tony Gibney to its Board of Directors
1 February 2018
InflaRx presents at two scientific conferences in February, 2018
9 January 2018
InflaRx receives IND acceptance to proceed with a Phase IIb Trial with lead candidate IFX-1 in Hidradenitis Suppurativa